Mustang Bio, Inc.
Hedge Funds Holdings
Last updated:
Mustang Bio, Inc.‘s stocks are currently a part of 68 hedge funds’ portfolios, which represents 18.73% of the total amount of its stocks outstanding. This makes up a total of 17.61M shares of Mustang Bio, Inc.. Compared to the previous quarter, the number fell by -30.17% or -7.61M shares fewer. As for the holding position changes, 20.59% (14) of current hedge fund investors increased the number of shares held, 38.24% (26) of current holders sold a part of the shares held, and 36.76% (25) closed the holdings completely. 16 hedge funds are new holders of Mustang Bio, Inc. stock in Q2 2022, it is 23.53% of total holders.
Hedge funds holding Mustang Bio (Q3 2017 – Q2 2022)
| Q3 2017 | 1 |
|---|---|
| Q4 2017 | 11 |
| Q1 2018 | 21 |
| Q2 2018 | 40 |
| Q3 2018 | 38 |
| Q4 2018 | 37 |
| Q1 2019 | 38 |
| Q2 2019 | 56 |
| Q3 2019 | 56 |
| Q4 2019 | 57 |
| Q1 2020 | 64 |
| Q2 2020 | 73 |
| Q3 2020 | 76 |
| Q4 2020 | 94 |
| Q1 2021 | 95 |
| Q2 2021 | 92 |
| Q3 2021 | 80 |
| Q4 2021 | 83 |
| Q1 2022 | 78 |
| Q2 2022 | 68 |
Hedge funds changes in Mustang Bio positions (Q3 2017 – Q2 2022)
| Q3 2017 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2017 | 10 | 1 | 0 | 0 | 0 |
| Q1 2018 | 10 | 7 | 4 | 0 | 0 |
| Q2 2018 | 24 | 9 | 3 | 5 | -1 |
| Q3 2018 | 4 | 15 | 9 | 6 | 4 |
| Q4 2018 | 4 | 8 | 15 | 5 | 5 |
| Q1 2019 | 4 | 11 | 15 | 3 | 5 |
| Q2 2019 | 24 | 22 | 2 | 4 | 4 |
| Q3 2019 | 7 | 19 | 15 | 6 | 9 |
| Q4 2019 | 7 | 24 | 13 | 6 | 7 |
| Q1 2020 | 13 | 16 | 18 | 6 | 11 |
| Q2 2020 | 18 | 29 | 10 | 8 | 8 |
| Q3 2020 | 14 | 26 | 21 | 10 | 5 |
| Q4 2020 | 25 | 36 | 17 | 8 | 8 |
| Q1 2021 | 14 | 36 | 23 | 13 | 9 |
| Q2 2021 | 12 | 41 | 18 | 15 | 6 |
| Q3 2021 | 7 | 28 | 26 | 18 | 1 |
| Q4 2021 | 13 | 34 | 20 | 10 | 6 |
| Q1 2022 | 11 | 13 | 33 | 15 | 6 |
| Q2 2022 | 16 | 14 | 26 | 25 | -13 |
Hedge funds changes in Mustang Bio stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 0 | 0 |
|---|---|---|
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 249,000 | 0 |
| Q3 2018 | 215,000 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 235,000 | 387,000 |
| Q3 2019 | 326,000 | 80,000 |
| Q4 2019 | 306,000 | 196,000 |
| Q1 2020 | 0 | 122,000 |
| Q2 2020 | 147,000 | 334,000 |
| Q3 2020 | 25,000,000,383,000 | 952,000 |
| Q4 2020 | 6,000,002,242,000 | 1,771,000 |
| Q1 2021 | 832,000 | 1,002,000 |
| Q2 2021 | 1,950,000 | 938,000 |
| Q3 2021 | 1,191,000 | 685,000 |
| Q4 2021 | 137,000 | 161,000 |
| Q1 2022 | 68,000 | 22,000 |
| Q2 2022 | 61,000 | 0 |